Condition: Keratoconus · Sponsor: Oslo University Hospital
The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK. The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.
This description comes directly from the study's public registry record.
Olav Kristianslund, MD, PhD · +4722118545 · olakri@ous-hf.no
Always discuss trial participation with your own doctor first.
| Department of Ophhtalmology, University of Oslo | Oslo, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06264024